Verition Fund Management LLC Astrazeneca PLC Transaction History
Verition Fund Management LLC
- $17.4 Billion
- Q3 2024
A detailed history of Verition Fund Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Verition Fund Management LLC holds 4,337 shares of AZN stock, worth $293,267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,337
Previous 12,741
65.96%
Holding current value
$293,267
Previous $993,000
66.06%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.25 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.84 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.52 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.49 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.29 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $210B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...